Preus i notícies sobre Tema GLP-1, Obesity & Cardiometabolic ETF (HRTS): Google Finance

Pàgina d'iniciHRTS • NASDAQ

Tema GLP-1, Obesity & Cardiometabolic ETF

33,66 $

30 de set., 7:01:10 GMT-4 · USD · NASDAQ · Exempció de responsabilitat

Tema Oncology ETF

28,35 $

CANC0,35 %

Tema Neuroscience and Mental Health ETF

26,33 $

MNTL0,62 %

ProShares Ultra Nasdaq Biotechnology

63,19 $

BIB0,29 %

Virtus LifeSci Biotech Products ETF

62,87 $

BBP0,97 %

Global X Genomics And Biotechnology ETF

11,15 $

GNOM1,13 %

VanEck Biotech ETF

176,49 $

BBH0,46 %

Franklin Genomic Advancements ETF

32,30 $

HELX0,21 %

iShares Biotechnology ETF

144,90 $

IBB0,46 %

SPDR S&P Biotech ETF

98,43 $

XBI0,24 %

First Trust NYSE Arca Biotechnology Index Fund

170,99 $

FBT0,69 %

ETFValor cotitzat de: EUA

Tancament anterior

33,64 $

Interval de preus d'avui

33,52 $ - 33,77 $

Interval anual

26,26 $ - 36,03 $

Volum mitjà

19,74 k

Notícies dels mercats

Yahoo Finance

fa 25 minuts

BioStem Technologies, Inc. Files Form 10 with the Securities and Exchange Commission and Submits Nasdaq Application for Uplisting

Broadening gains in US stock market underscore optimism on economy

The S&P 500 Is Rebounding: 2 Tech Stocks to Buy Now, According to These Wall Street Analysts

Crypto Exchange Bithumb Weighs U.S. Nasdaq Listing: Report

Stock Market Today: What to Watch

Bloomberg.com

fa 1 hora

RBC’s Calvasina Modeling S&P 500 at 6,200 in 2025

.INX

0,13 %